Truvestments Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46K Sell
54
-59
-52% -$3.88K ﹤0.01% 956
2026
Q1
$8.04K Hold
113
– – ﹤0.01% 801
2025
Q4
$9.27K Hold
113
– – ﹤0.01% 713
2025
Q3
$8.49K Buy
113
+59
+109% +$4.4K ﹤0.01% 738
2025
Q2
$4K Sell
54
-21
-28% -$1.46K ﹤0.01% 760
2025
Q1
$6.05K Buy
75
+11
+17% +$945 ﹤0.01% 734
2024
Q4
$5K Buy
64
+10
+19% +$850 ﹤0.01% 702
2024
Q3
$5.07K Buy
+54
New +$4.53K ﹤0.01% 684
2024
Q1
– Sell
-146
Closed -$12.1K – 727
2023
Q4
$11.3K Buy
146
+62
+74% +$4.34K 0.01% 510
2023
Q3
$5.72K Hold
84
– – ﹤0.01% 499
2023
Q2
$6.83K Buy
84
+22
+35% +$1.76K ﹤0.01% 494
2023
Q1
$5.09K Buy
+62
New +$4.43K ﹤0.01% 511

Other funds holding GEHC

Truvestments Capital's GEHC Position: Q2 2026 in Review

Truvestments Capital reduced its GE HealthCare (GEHC) stake by 52% in Q2 2026, selling an estimated $3.88K and leaving 54 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Truvestments Capital first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $11.3K in Q4 2023. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Truvestments Capital held 54 shares of GE HealthCare worth $3.46K as of Q2 2026.
  • Truvestments Capital sold 59 GE HealthCare shares in Q2 2026, an estimated $3.88K.
  • GE HealthCare made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #956 holding.
  • Truvestments Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • Truvestments Capital's GE HealthCare position peaked at $11.3K in Q4 2023.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.